In addition, though we have presently not observed modification of MIF and DDT expression in response to treatment, it will be interesting to evaluate in larger cohorts of DLE patients whether or not the insufficient expression of MIF and DDT in the cutaneous lesions may be associated with a poorer therapeutic response. This evidence concerns the gene MIF and discoid lupus erythematosus.